Get the app
public
ios_share
OncoPharm
chevron_right
Monthly Immunotherapy Expanded Approvals Update
Oct 21, 2020
14:57
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
Another month, another 2 expanded FDA-approvals: nivolumab/ipilimumab for malignant pleural mesothelioma and pembrolizumab for relapsed/refractory classical Hodgkin's lymphoma.
